eIF4A/PDCD4 Pathway, a Factor for Doxorubicin Chemoresistance in a Triple-Negative Breast Cancer Cell Model.
González-Ortiz A, Pulido-Capiz A, Castañeda-Sánchez CY, Ibarra-López E, Galindo-Hernández O, Calderón-Fernández MA, López-Cossio LY, Díaz-Molina R, Chimal-Vega B, Serafín-Higuera N, Córdova-Guerrero I, García-González V.
González-Ortiz A, et al. Among authors: galindo hernandez o.
Cells. 2022 Dec 15;11(24):4069. doi: 10.3390/cells11244069.
Cells. 2022.
PMID: 36552834
Free PMC article.